News Archive

Inova Personalized Health Accelerator (IPHA) has selected HeMemics Biotechnologies, Inc. (HBI) as its first portfolio company. HBI is a research and development company located in Rockville, MD that develops rapid diagnostic test platforms to detect various bacterial and viral pathogens. The company’s technology detects, within 15 seconds, the absence or presence of a specific virus or bacterium when an aqueous sample is placed on an electronic chip. HeMemics invented and patented “HemSol™,” a method to preserve cells and biological entities for an extended period of time. The preservation method in conjunction with the low cost HeMemics prototype electronic chip and portable, battery-powered reading device are designed to be deployed for Point of Care (POC) diagnostics. Typically, pathogen detection involves laboratory analysis which delays inpatient treatment or requires a return visit for outpatients.

When Venture Capitalists (VCs) invest in startups, they are aware of risks involved in returns- it might be either mind-boggling or they might end up taking a lot of losses. But VC hits are much talked about and at the same time, not all predictions come true. Some venture capital firms make successful exits and it shows the growth of the startup ecosystem.

The internet has become a crucial gateway for accessing information. Just look around Brody Café or wherever you’re reading this piece: People are writing papers, conducting research, reading articles, buying a new pair of shoes or watching TV, all through the internet. Whether it is education, business or entertainment, the internet has become a practical necessity for us to engage in society today. For our democracy and economy to function, it is paramount that people have equal access to the internet.

Recent news surrounding the nation’s growing opioid epidemic has demonstrated how an all-hands-on-deck approach is needed when a serious national health crisis threatens the lives of Americans. The Trump administration declared opioid abuse a public health emergency, and lawmakers have enacted legislation to expand treatment and prevention programs, as well as prosecute individuals who commit opioid-related health care fraud.

In a spare bedroom of his family’s house in County Cork, Ireland, Cathal Garvey is repeating the feats that led to the dawn of the biotechnology age. He’s growing bacteria. He’s adding DNA. He’s seeing what happens.

Barbara Crews, assistant executive director for community relations at the Johns Hopkins University Montgomery County Campus, has been tapped to serve as chair of the board of the Gaithersburg-Germantown Chamber of Commerce.

Crews previously served the Chamber as a board member; vice chair for member recruitment and retention; and most recently as chair-elect. She has been involved with the Chamber since 2014.

An artificial pancreas to help diabetics. A pacemaker for sleep apnea.  Gene therapy for blindness. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of doctors and researchers.

Investors in the Malvern biopharmaceutical company include Silicon Valley Bank.

The Princeton Review looked at more than 2,000 colleges and universities to find the best ones that will set entrepreneurs up for success.

Halcyon, a nonprofit dedicated to supporting early-stage social entrepreneurs, today announces its eighth cohort for the Halcyon Incubator program. With an acceptance rate of less than 3%, Halcyon is bringing social enterprises that focus on big ideas tackling some of the most current and prevalent societal issues today.